Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-10-28 06:00 am Purchase | 13G | Monopar Therapeutics MNPR | ASTRAZENECA PLC AZN | 387,329 9.900% | 387,329 (New Position) | View |
| 2024-10-11 06:01 am Purchase | 13G | CONDUIT PHARMACEUTICALS INC. CDT | ASTRAZENECA PLC AZN | 9,504,465 9.900% | 9,504,465 (New Position) | View |
| 2024-02-12 10:13 am Unchanged | 13G | ADC Therapeutics SA ADCT | ASTRAZENECA PLC AZN | 4,011,215 4.880% | 0 (Unchanged) | View |
| 2024-01-24 5:23 pm Sale | 13G | ASTRAZENECA PLC AZN | BlackRock Inc. BLK | 140,325,832 9.100% | -8,700,570 (-5.84%) | View |
| 2023-11-16 11:16 am Unchanged | 13D | CELLECTIS S A SPONSORED ADS CLLS | ASTRAZENECA PLC AZN | 16,000,000 22.400% | 0 (Unchanged) | View |
| 2023-11-09 5:07 pm Purchase | 13D | CELLECTIS S A SPONSORED ADS CLLS | ASTRAZENECA PLC AZN | 16,000,000 22.400% | 16,000,000 (New Position) | View |
| 2023-02-10 10:25 am Unchanged | 13G | ARIDIS PHARMACEUTICALS INC ARDS | ASTRAZENECA PLC AZN | 884,956 3.400% | 0 (Unchanged) | View |
| 2023-02-10 10:22 am Unchanged | 13G | PALVELLA THERAPEUTICS INC. PVLA | ASTRAZENECA PLC AZN | 3,584,230 4.800% | 0 (Unchanged) | View |
| 2023-01-24 1:56 pm Sale | 13G | ASTRAZENECA PLC AZN | BlackRock Inc. BLK | 149,026,402 9.600% | -8,364,904 (-5.31%) | View |
| 2022-07-08 4:56 pm Purchase | 13G | ASTRAZENECA PLC AZN | BlackRock Inc. BLK | 157,391,306 10.200% | 18,458,884 (+13.29%) | View |
| 2022-02-07 4:33 pm Purchase | 13G | ASTRAZENECA PLC AZN | BlackRock Inc. BLK | 138,932,422 9.000% | 23,755,621 (+20.63%) | View |
| 2022-02-04 09:06 am Sale | 13G | ASTRAZENECA PLC AZN | WELLINGTON MANAGEMENT GROUP LLP | 65,542,362 4.230% | -2,982,967 (-4.35%) | View |
| 2021-07-27 1:20 pm Purchase | 13G | ARIDIS PHARMACEUTICALS INC ARDS | ASTRAZENECA PLC AZN | 884,956 7.300% | 884,956 (New Position) | View |
| 2021-04-07 5:37 pm Purchase | 13G | PALVELLA THERAPEUTICS INC. PVLA | ASTRAZENECA PLC AZN | 3,584,230 5.660% | 3,584,230 (New Position) | View |
| 2021-02-10 4:01 pm Purchase | 13G | ADC Therapeutics SA ADCT | ASTRAZENECA PLC AZN | 4,011,215 5.230% | 4,011,215 (New Position) | View |
| 2021-02-10 4:01 pm Sale | 13G | Moderna Inc. MRNA | ASTRAZENECA PLC AZN | 0 0.000% | -25,499,325 (Position Closed) | View |
| 2021-02-03 1:13 pm Sale | 13G | ASTRAZENECA PLC AZN | WELLINGTON MANAGEMENT GROUP LLP | 68,525,329 5.220% | -8,978,560 (-11.58%) | View |
| 2021-01-28 6:11 pm Purchase | 13G | ASTRAZENECA PLC AZN | BlackRock Inc. BLK | 115,176,801 8.800% | 10,100,809 (+9.61%) | View |
| 2020-02-07 12:56 pm Purchase | 13D | Aevi Genomic Medicine Inc. GNMX | ASTRAZENECA PLC AZN | 12,946,900 16.700% | 12,946,900 (New Position) | View |
| 2020-02-05 11:38 am Purchase | 13G | ASTRAZENECA PLC AZN | BlackRock Inc. BLK | 105,075,992 8.000% | 1,874,337 (+1.82%) | View |